Here are the Form 4 insider transactions from AstraZeneca PLC (AZNCF) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow AZNCF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AZNCF filings page.
ASTRAZENECA PLC officer Sharma Mani reported an open-market sale of 11,893 Ordinary Shares on May 20, 2026 at an average price of $185.78 per share, based on a GBP139.35 price and a stated currency conversion rate. After this transaction, Mani directly holds 19,262.4659 Ordinary Shares.
AstraZeneca PLC officer Sharma Mani reported routine share awards under the company’s Share Incentive Plan. On April 7, 2026, Mani acquired 1 Ordinary Share at $196.03, and on May 6, 2026, acquired 1 Ordinary Share at $186.28, both as grants rather than open-market purchases.
After these awards, Mani directly held a total of 31,155.4659 Ordinary Shares. The award prices reflect conversions from GBP148.06 and GBP136.76 using Federal Reserve exchange rates published in April and May 2026.